Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 09:39 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | FL | 70 beds | Grade C | EBITDA uplift $2.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 103037 | PINELLAS, FL | 70 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 70-bed suburban community hospital in PINELLAS, FL with $34.4M in net patient revenue and a 18.3% operating margin. The hospital serves a payer mix of 62.1% Medicare, 0.4% Medicaid, and 37.6% commercial.

Thesis: Turnaround. Our ML models identify $2.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 18.3% to 25.6% (+736bps).

Net Revenue HCRIS$34.4M
Current EBITDA COMPUTED$6.3M
Operating Margin COMPUTED18.3%
Occupancy HCRIS89.9%
Revenue / Bed COMPUTED$491K
Net-to-Gross HCRIS77.0%
Distress Probability ML45.6%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
114
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 18.3% places it above the state median. Among 114 size-comparable peers (35-140 beds), the median margin is 3.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (35-140), prioritizing same-state peers. 114 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)FL70$34.4M18.3%
WEST KENDALL BAPTIST HOSPITALFL127$361.6M18.5%
ADVENTHEALTH PALM COASTFL99$285.7M8.1%
NEMOURS CHILDRENS HOSPITALFL130$268.7M-10.2%
DOCTORS HOSPITALFL130$250.0M0.9%
ASCENSION SACRED HEART BAYFL126$192.1M-6.7%
ASCENSION SACRED HEART EMERALDFL80$187.9M16.1%
HCA FLORIDA SARASOTA DOCTORS HFL139$183.8M17.3%
BAPTIST MEDICAL CENTER-BEACHESFL135$173.6M2.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$722K+210bp18mo
Cost to Collect4.5%2.5%$687K+200bp12mo
Denial Rate Reduction12.0%6.5%$680K+198bp12mo
A/R Days Reduction5200.0%3800.0%$418K+122bp9mo
Clean Claim Rate88.0%96.0%$22K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$722K
Cost to Collect
$687K
Denial Rate Reduction
$680K
A/R Days Reduction
$418K
Clean Claim Rate
$22K
Total EBITDA Uplift$2.5M
Current EBITDA$6.3M
+ RCM Uplift+$2.5M
Pro Forma EBITDA$8.8M
Current Margin18.3%
Pro Forma Margin25.6%
WC Released (1x)$1.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$9.7M$66.7M6.91x47.2%
Base (11x exit)10.0x11.0x$9.7M$76.5M7.92x51.3%
Bull Case9.0x11.0x$8.7M$88.0M10.12x58.9%
Bull (12x exit)9.0x12.0x$8.7M$98.6M11.34x62.5%
Bear Case11.0x10.0x$10.6M$50.9M4.79x36.8%
Bear (11x exit)11.0x11.0x$10.6M$59.5M5.60x41.1%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 62.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 114 hospitals with 35-140 beds
  • Same-state prioritization (n=115)
  • Comp margins: P25=-9.7% / P50=3.4% / P75=11.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.